Findings from a pilot open-label trial of N-acetylcysteine for the treatment of pediatric mania and hypomania

BACKGROUND: Pediatric bipolar disorder is a highly prevalent and morbid disorder and is considered a prevalent public health concern. Currently approved treatments often pose the risk of serious side effects. Therefore, this study assessed the efficacy and tolerability of N-acetylcysteine (NAC), in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wozniak, Janet, DiSalvo, Maura, Farrell, Abigail, Vaudreuil, Carrie, Uchida, Mai, Ceranoglu, T. Atilla, Joshi, Gagan, Cook, Emmaline, Faraone, Stephen V., Biederman, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066881/
https://www.ncbi.nlm.nih.gov/pubmed/35505312
http://dx.doi.org/10.1186/s12888-022-03943-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066881/
https://www.ncbi.nlm.nih.gov/pubmed/35505312
http://dx.doi.org/10.1186/s12888-022-03943-x

Ejemplares similares